Physician profile
James S Sinclair
NPI 1437142320
$1,247.50
in general payments reported to CMS, 2019-2025
21 companies · $13.96 in 2025
The $13.96 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $162 · 2021: $436 · 2022: $104 · 2023: $147 · 2024: $115 · 2025: $13.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $269.02 | 2019-2023 | Veozah |
| Galderma Laboratories, L.P. | $130.38 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $118.76 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $115.01 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $106.63 | 2019-2021 | |
| Abbvie INC. | $92.79 | 2021-2024 | Vraylar |
| Astrazeneca Pharmaceuticals Lp | $84.69 | 2020-2025 | Farxiga |
| Supernus Pharmaceuticals, INC. | $54.28 | 2019-2020 | |
| Glaxosmithkline, LLC. | $44.99 | 2022 | |
| Sumitomo Pharma America, INC. | $41.21 | 2023-2024 | Aptiom |
| Amgen INC. | $30.51 | 2021-2024 | Krystexxa |
| Corium, LLC | $17.74 | 2023 | Azstarys |
| Avanir Pharmaceuticals, INC. | $17.66 | 2021 | |
| Revance Therapeutics, INC. | $17.48 | 2024 | Daxxify |
| Ferring Pharmaceuticals INC. | $17.32 | 2023 | Clenpiq |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $16.75 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.69 | 2020 | |
| Baxter Healthcare | $15.22 | 2023 | Hillrom - Life 2000 Ventilation System |
| Corcept Therapeutics | $14.00 | 2023 | Korlym |
| Lilly USA, LLC | $13.96 | 2024 | Jardiance |
| Pfizer INC. | $13.41 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Sinclair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.